DOW JONES25,766.64-1190.95 -4.42%
S&P 5002,978.76-137.63 -4.42%
NASDAQ8,566.48-414.30 -4.61%

H.C. Wainwright Earlier Maintained Buy on Aravive, Lowered Price Target to $25

H.C. Wainwright analyst Joseph Pantginis maintains Aravive (NASDAQ:ARAV) with a Buy and lowers the price target from $31 to $25.

Benzinga · 12/20/2019 18:49

H.C. Wainwright analyst Joseph Pantginis maintains Aravive (NASDAQ:ARAV) with a Buy and lowers the price target from $31 to $25.